These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

174 related items for PubMed ID: 9193748

  • 21. Ex vivo anti-CD3 antibody-activated donor T cells have a reduced ability to cause lethal murine graft-versus-host disease but retain their ability to facilitate alloengraftment.
    Drobyski WR, Majewski D, Ozker K, Hanson G.
    J Immunol; 1998 Sep 01; 161(5):2610-9. PubMed ID: 9725263
    [Abstract] [Full Text] [Related]

  • 22. Similar survival following HLA-identical sibling transplantation for standard indication in children with haematologic malignancies: a single center comparison of mobilized peripheral blood stem cell with bone marrow transplantation.
    Meisel R, Enczmann J, Balzer S, Bernbeck B, Kramm C, Schönberger S, Sinha K, Tröger A, Wernet P, Göbel U, Laws HJ, Dilloo D.
    Klin Padiatr; 2005 Sep 01; 217(3):135-41. PubMed ID: 15858704
    [Abstract] [Full Text] [Related]

  • 23. Exacerbation of Plasmodium chabaudi malaria in mice by depletion of TCR alpha beta+ T cells, but not TCR gamma delta+ T cells.
    Sayles PC, Rakhmilevich L.
    Immunology; 1996 Jan 01; 87(1):29-33. PubMed ID: 8666432
    [Abstract] [Full Text] [Related]

  • 24. Phenotypic analysis of donor cells infiltrating the small intestinal epithelium and spleen during graft-versus-host disease.
    Schattenfroh NC, Hoffman RA, McCarthy SA, Simmons RL.
    Transplantation; 1995 Jan 27; 59(2):268-73. PubMed ID: 7839451
    [Abstract] [Full Text] [Related]

  • 25. Alteration of the T cell repertoire after bone marrow transplantation.
    Villers D, Milpied N, Gaschet J, Davodeau F, Hallet MM, Bonneville M, Vié H.
    Bone Marrow Transplant; 1994 Jan 27; 13(1):19-26. PubMed ID: 8019449
    [Abstract] [Full Text] [Related]

  • 26. Bone marrow transplantation from partially HLA-mismatched family donors for acute leukemia: single-center experience of 201 patients.
    Mehta J, Singhal S, Gee AP, Chiang KY, Godder K, Rhee Fv Fv, DeRienzo S, O'Neal W, Lamb L, Henslee-Downey PJ.
    Bone Marrow Transplant; 2004 Feb 27; 33(4):389-96. PubMed ID: 14716338
    [Abstract] [Full Text] [Related]

  • 27. Role of immunoregulatory donor T cells in suppression of graft-versus-host disease following donor leukocyte infusion therapy.
    Johnson BD, Becker EE, LaBelle JL, Truitt RL.
    J Immunol; 1999 Dec 15; 163(12):6479-87. PubMed ID: 10586039
    [Abstract] [Full Text] [Related]

  • 28. A new marrow T cell depletion method using anti-CD6 monoclonal antibody-conjugated magnetic beads and its clinical application for prevention of acute graft-vs.-host disease in allogeneic bone marrow transplantation: results of a phase I-II trial.
    Sao H, Kitaori K, Kasai M, Shimokawa T, Kato C, Yamanishi H, Ueda R, Morishima Y.
    Int J Hematol; 1999 Jan 15; 69(1):27-35. PubMed ID: 10641440
    [Abstract] [Full Text] [Related]

  • 29. Prophylactic T cell infusion after T cell-depleted bone marrow transplantation in patients with refractory lymphoma.
    Lee CK, de Magalhaes-Silverman M, Hohl RJ, Hayashi M, Buatti J, Wen BC, Schlueter A, Strauss RG, Gingrich RD.
    Bone Marrow Transplant; 2002 Apr 15; 29(7):615-20. PubMed ID: 11979313
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Graft-vs.-host and graft-vs.-leukemia reactions after delayed infusions of donor T-subsets.
    Johnson BD, Becker EE, Truitt RL.
    Biol Blood Marrow Transplant; 1999 Apr 15; 5(3):123-32. PubMed ID: 10392958
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Selective T cell depletion of donor allogeneic marrow with anti-CD6 monoclonal antibody: rationale and results.
    Soiffer RJ, Ritz J.
    Bone Marrow Transplant; 1993 Apr 15; 12 Suppl 3():S7-10. PubMed ID: 8124262
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. [Clinical study of a new protocol for acute graft-versus host disease prophylaxis in HLA-haploidentical bone marrow transplantation (BMT)].
    Ji SQ, Chen HR, Wang HX, Yan HM, Liu J, Xue M, Zhu L.
    Zhonghua Xue Ye Xue Za Zhi; 2003 Aug 15; 24(8):416-9. PubMed ID: 14642179
    [Abstract] [Full Text] [Related]

  • 38. Unrelated donor bone marrow transplantation for children with severe aplastic anemia: minimal GVHD and durable engraftment with partial T cell depletion.
    Bunin N, Aplenc R, Iannone R, Leahey A, Grupp S, Monos D, Pierson G.
    Bone Marrow Transplant; 2005 Feb 15; 35(4):369-73. PubMed ID: 15640818
    [Abstract] [Full Text] [Related]

  • 39. Treatment of steroid-resistant acute graft-versus-host disease with an anti-IL-2-receptor monoclonal antibody (BT 563) in children who received T cell-depleted, partially matched, related bone marrow transplants.
    Herbelin C, Stephan JL, Donadieu J, Le Deist F, Racadot E, Wijdenes J, Fischer A.
    Bone Marrow Transplant; 1994 May 15; 13(5):563-9. PubMed ID: 8054909
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.